Home Cart 0 Sign in  
X

[ CAS No. 17249-80-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 17249-80-8
Chemical Structure| 17249-80-8
Chemical Structure| 17249-80-8
Structure of 17249-80-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 17249-80-8 ]

Related Doc. of [ 17249-80-8 ]

Alternatived Products of [ 17249-80-8 ]

Product Details of [ 17249-80-8 ]

CAS No. :17249-80-8 MDL No. :MFCD00043887
Formula : C4H3ClS Boiling Point : -
Linear Structure Formula :- InChI Key :QUBJDMPBDURTJT-UHFFFAOYSA-N
M.W : 118.58 Pubchem ID :87017
Synonyms :

Calculated chemistry of [ 17249-80-8 ]

Physicochemical Properties

Num. heavy atoms : 6
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 0.0
Num. H-bond donors : 0.0
Molar Refractivity : 29.33
TPSA : 28.24 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.21 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.89
Log Po/w (XLOGP3) : 2.55
Log Po/w (WLOGP) : 2.4
Log Po/w (MLOGP) : 1.8
Log Po/w (SILICOS-IT) : 3.36
Consensus Log Po/w : 2.4

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 3.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.8
Solubility : 0.189 mg/ml ; 0.00159 mol/l
Class : Soluble
Log S (Ali) : -2.79
Solubility : 0.192 mg/ml ; 0.00162 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.23
Solubility : 0.697 mg/ml ; 0.00587 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.64

Safety of [ 17249-80-8 ]

Signal Word:Danger Class:3,8
Precautionary Statements:P261-P280-P305+P351+P338 UN#:2924
Hazard Statements:H225-H302-H315-H318-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 17249-80-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 17249-80-8 ]
  • Downstream synthetic route of [ 17249-80-8 ]

[ 17249-80-8 ] Synthesis Path-Upstream   1~24

  • 1
  • [ 188290-36-0 ]
  • [ 17249-80-8 ]
Reference: [1] Journal of the American Chemical Society, 1953, vol. 75, p. 3517
  • 2
  • [ 540-59-0 ]
  • [ 74-86-2 ]
  • [ 188290-36-0 ]
  • [ 96-43-5 ]
  • [ 17249-80-8 ]
  • [ 95-15-8 ]
Reference: [1] Russian Chemical Bulletin, 1996, vol. 45, # 3, p. 662 - 666
[2] Russian Chemical Bulletin, 1996, vol. 45, # 3, p. 662 - 666
  • 3
  • [ 75-35-4 ]
  • [ 188290-36-0 ]
  • [ 96-43-5 ]
  • [ 17249-80-8 ]
  • [ 79552-37-7 ]
Reference: [1] Journal of Organic Chemistry USSR (English Translation), 1981, vol. 17, p. 975 - 976[2] Zhurnal Organicheskoi Khimii, 1981, vol. 17, # 5, p. 1103
[3] Journal of Organic Chemistry USSR (English Translation), 1981, vol. 17, p. 975 - 976[4] Zhurnal Organicheskoi Khimii, 1981, vol. 17, # 5, p. 1103
  • 4
  • [ 96-43-5 ]
  • [ 188290-36-0 ]
  • [ 17249-80-8 ]
Reference: [1] Angewandte Chemie, 1987, vol. 99, # 5, p. 470 - 471
  • 5
  • [ 75-35-4 ]
  • [ 96-43-5 ]
  • [ 17249-80-8 ]
  • [ 79552-39-9 ]
  • [ 79552-37-7 ]
Reference: [1] Journal of Organic Chemistry USSR (English Translation), 1981, vol. 17, p. 975 - 976[2] Zhurnal Organicheskoi Khimii, 1981, vol. 17, # 5, p. 1103
  • 6
  • [ 75-35-4 ]
  • [ 96-43-5 ]
  • [ 17249-80-8 ]
  • [ 79552-38-8 ]
  • [ 79552-37-7 ]
Reference: [1] Journal of Organic Chemistry USSR (English Translation), 1981, vol. 17, p. 975 - 976[2] Zhurnal Organicheskoi Khimii, 1981, vol. 17, # 5, p. 1103
  • 7
  • [ 126714-85-0 ]
  • [ 17249-80-8 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1937, vol. 532, p. 250,279
  • 8
  • [ 872-31-1 ]
  • [ 17249-80-8 ]
Reference: [1] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1993, vol. 29, # 8, p. 889 - 891[2] Khimiya Geterotsiklicheskikh Soedinenii, 1993, # 8, p. 1046 - 1048
[3] Chemical Communications, 2014, vol. 50, # 18, p. 2344 - 2346
  • 9
  • [ 96-43-5 ]
  • [ 17249-80-8 ]
Reference: [1] Angewandte Chemie, 1987, vol. 99, # 5, p. 470 - 471
  • 10
  • [ 75-35-4 ]
  • [ 188290-36-0 ]
  • [ 96-43-5 ]
  • [ 17249-80-8 ]
  • [ 79552-39-9 ]
  • [ 79552-38-8 ]
  • [ 79552-37-7 ]
Reference: [1] Journal of Organic Chemistry USSR (English Translation), 1981, vol. 17, p. 975 - 976[2] Zhurnal Organicheskoi Khimii, 1981, vol. 17, # 5, p. 1103
  • 11
  • [ 17249-80-8 ]
  • [ 557-21-1 ]
  • [ 1641-09-4 ]
Reference: [1] Organic and Biomolecular Chemistry, 2017, vol. 15, # 20, p. 4291 - 4294
  • 12
  • [ 17249-80-8 ]
  • [ 1641-09-4 ]
Reference: [1] Angewandte Chemie - International Edition, 2013, vol. 52, # 38, p. 10035 - 10039[2] Angew. Chem., 2013, vol. 125, # 38, p. 10219 - 10223
  • 13
  • [ 17249-80-8 ]
  • [ 557-21-1 ]
  • [ 1641-09-4 ]
Reference: [1] Tetrahedron Letters, 2010, vol. 51, # 37, p. 4833 - 4836
  • 14
  • [ 17249-80-8 ]
  • [ 1641-09-4 ]
Reference: [1] Organometallics, 2013, vol. 32, # 12, p. 3537 - 3543
  • 15
  • [ 17249-80-8 ]
  • [ 1071-36-9 ]
  • [ 13781-53-8 ]
Reference: [1] Angewandte Chemie - International Edition, 2011, vol. 50, # 19, p. 4470 - 4474
  • 16
  • [ 17249-80-8 ]
  • [ 201230-82-2 ]
  • [ 22913-26-4 ]
  • [ 88-13-1 ]
Reference: [1] Journal of Organic Chemistry, 1995, vol. 60, # 26, p. 8336 - 8340
  • 17
  • [ 17249-80-8 ]
  • [ 67-56-1 ]
  • [ 201230-82-2 ]
  • [ 22913-26-4 ]
  • [ 88-13-1 ]
Reference: [1] Journal of Organic Chemistry, 1995, vol. 60, # 26, p. 8336 - 8340
  • 18
  • [ 17249-80-8 ]
  • [ 6165-69-1 ]
Reference: [1] Organic Letters, 2012, vol. 14, # 18, p. 4814 - 4817,4
  • 19
  • [ 17249-80-8 ]
  • [ 124-38-9 ]
  • [ 59337-89-2 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 2012, vol. 85, # 3, p. 369 - 371
  • 20
  • [ 17249-80-8 ]
  • [ 124-38-9 ]
  • [ 59337-89-2 ]
  • [ 59614-95-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2016, vol. 59, # 7, p. 3471 - 3488
  • 21
  • [ 17249-80-8 ]
  • [ 1692-15-5 ]
  • [ 21308-82-7 ]
Reference: [1] Journal of the American Chemical Society, 2007, vol. 129, # 11, p. 3358 - 3366
  • 22
  • [ 17249-80-8 ]
  • [ 88303-25-7 ]
  • [ 110851-66-6 ]
Reference: [1] Angewandte Chemie - International Edition, 2002, vol. 41, # 4, p. 609 - 612
[2] Journal of the American Chemical Society, 2002, vol. 124, # 46, p. 13856 - 13863
[3] Patent: US2003/220498, 2003, A1, . Location in patent: Page/Page column 6
  • 23
  • [ 17249-80-8 ]
  • [ 77893-68-6 ]
YieldReaction ConditionsOperation in experiment
100% With N-Bromosuccinimide; acetic acid In chloroform for 1.5 h; Reflux Compound 28-1 (0457) To a solution of 3-chlorothiophene (6.52 g, 55 mmol) in CHCl3 (30 mL) and AcOH (30 mL) was added NBS (9.80 g, 55 mmol). The mixture was heated at relux for 1.5 h, then cooled to room temperature. Water (70 mL) was added and the mixture was extracted with CHCl3 (30 mL×2). The combined organic layers were washed with sat. NaHCO3 (40 mL) and brine (30 mL), dried over anhydrous Na2SO4, filtered, concentrated to afford 28-1 as a brown oil (10.02 g, quantitive yield) which used for the next step directly.
93% With N-Bromosuccinimide; acetic acid In chloroform at 20℃; for 18 h; Inert atmosphere; Cooling with ice Under a nitrogen atmosphere, 3-chloro-thiophene 300ml three-necked flask (Sigma - Aldrich) 1.18 g (0.010 mol), chloroform 10ml and acetic acid was added 10ml.Under ice-cooling N- bromosuccinimide (manufactured by Wako Pure Chemical Industries) 1.96 g of (0.011 mol) was added dropwise and stirred for 18 hours at room temperature.Ice-cold sewage added to the reaction solution, followed by extraction with chloroform, the organic phase was washed with brine, dried over anhydrous sodium sulfate, to give a colorless liquid 1.84g of 2-bromo-3-chloro-thiophene (yield: 93percent).
53% With bromine In tetrachloromethane at 0 - 60℃; for 18 h; Example 1080 Neat bromine (0.8 mL, 24 mmol, 0.9 eq) was added dropwise over ~20 min to a stirred solution of Compound 1080A (2.00 g, 0.026 mmol) in carbon tetrachloride (4 mL) at 0 0C. Upon completion of the addition, the reaction mixture was heated at 60 deg:C for 18 h. The reaction mixture was diluted with Et&2O (50 mL), and was washed sequentially with saturated aq sodium bicarbonate (50 mL) and brine (-50 ml_). The organic phase was dried over anhydrous MgSO4, filtered, and concentrated. The desired product 1080B was purified by sgc (100percent hexanes, isocratic) to give Compound 1080B as a clear, colorless liquid (1.78 g, 53percent)
97% With N-Bromosuccinimide; perchloric acid In <i>N</i>-methyl-acetamide A solution of N-bromosuccinimide (221.7 g) in dimethylformamide (550 ml) was added dropwise over 75 min to a stirred solution of 3-chlorothiophene (143.4 g) and perchloric acid (70percent, 5.8 ml) cooled in an ice-water bath at 15° C.
The reaction temperature gradually rose to 40° C. over 30 min and then was cooled to 11° C.
Cooling was removed and the reaction was stirred for a further 2 h.
The reaction was poured into water and exacted with methyltertbutyl ether.
The organic extract was sequentially washed with water, aq. sodium hydrogen sulphite solution and water, dried (Na2SO4) and evaporated to dryness.
The residual oil (246 g) was distilled under vacuum in an oil bath at 80-90° C. to give 2-bromo3-chloro-thiophene as an oil (202 g (97percent); b pt 42° C. (1 mm Hg).

Reference: [1] Patent: US9138427, 2015, B2, . Location in patent: Page/Page column 304
[2] Patent: JP2015/227295, 2015, A, . Location in patent: Paragraph 0047
[3] Synthetic Communications, 1994, vol. 24, # 1, p. 95 - 101
[4] Journal of Medicinal Chemistry, 1981, vol. 24, # 8, p. 959 - 964
[5] Patent: WO2007/84451, 2007, A1, . Location in patent: Page/Page column 154
[6] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 3, p. 617 - 620
[7] Patent: US6288085, 2001, B1,
[8] Patent: WO2013/119895, 2013, A1, . Location in patent: Page/Page column 72
[9] Patent: WO2014/98831, 2014, A1, . Location in patent: Page/Page column 64
[10] Patent: WO2018/160878, 2018, A1, . Location in patent: Page/Page column 309
  • 24
  • [ 17249-80-8 ]
  • [ 124-38-9 ]
  • [ 59337-89-2 ]
  • [ 59614-95-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2016, vol. 59, # 7, p. 3471 - 3488
Same Skeleton Products
Historical Records